Clinical Trial

Risperidone vs Cariprazine in Acute Mania

Name: Risperidone vs Cariprazine in Acute Mania — clinical trial record (NCT07665073)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: RCAM

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

Randomized, double-blind, parallel-group study comparing efficacy and safety of Risperidone versus Cariprazine in adults with acute manic episodes. Participants will receive oral study drug for 6 weeks. Primary outcome is change in YMRS total score from baseline to week 6.

Trial Details

NCT Number	NCT07665073
Lead Sponsor	Pakistan Institute of Medical Sciences
Conditions	Bipolar 1 Disorder
Enrollment	50 participants
Start Date	2027-06
Primary Completion	2028-06 (estimated)
Study Completion	2028-06 (estimated)
Updated on ClinicalTrials.gov	2026-06-24